Phibro Animal Health | PAHC - 债务利息支出

金融业

USD 35.97

USD 1.51B

现金及等价物

USD 75.55M

USD 240.42M

USD 945.17M

USD 295.79M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 417.67M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 585.85M

USD 1.44B

USD 27.46M

USD 417.67M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 567.14M

贸易债权人

USD 136.45M

应收帐款人

USD 215.87M

	债务利息支出	更改		日
Align Technology	USD 9.96M		3.02M	2026-06
ANI Pharmaceuticals	USD 3.06M		580K	2026-09
Aurora Cannabis	CAD 464K		234K	2026-06
Bristol-Myers Squibb	USD 403M		4M	2026-09
Canopy Growth	CAD 12.68M		364K	2026-06
Corcept Therapeutics	USD 1.03B		145.32M	2026-09
Eli Lilly	USD 316M		201.3M	2026-09
Henry Schein	USD 42M		1000K	2026-09
Idexx Laboratories	USD 7.46M		2.72M	2026-09
Knight Therapeutics	CAD 3.92M		1.56M	2025-12
Merck	USD 525M		46M	2026-06
Nektar Therapeutics	USD 7.94M		1.83M	2026-03
Pacira	USD 112.4M		108.78M	2026-09
Phibro Animal Health	USD 11.91M		191K	2025-12
Prestige Brands	USD 13.94M		2.52M	2026-06
Supernus Pharmaceuticals	USD 718K		1.6M	2026-09
Zoetis	USD 62M		1000K	2026-09